In vitro cultures of MSA patient-derived induced pluripotent stem cells (iPSCs) showed that α-synuclein is only expressed in the early stages of oligodendrocyte maturation but not in the premyelination period31. The gene discussed is SNCA; the disease is multiple system atrophy.